|4Feb 7, 7:38 PM ET

ENGELSEN STEINAR J 4

4 · SOLENO THERAPEUTICS INC · Filed Feb 7, 2018

Insider Transaction Report

Form 4
Period: 2018-02-05
Transactions
  • Award

    Common Stock

    2018-02-05$1.73/sh+8,109$13,99941,831 total
Footnotes (3)
  • [F1]Effective January 1, 2017, annual board and committee retainers payable to directors will be made in equivalent shares of the Issuer's common stock, on a quarterly basis.
  • [F2]The number of shares issuable in lieu of cash retainers was determined using the closing price per share of Issuer common stock on February 2, 2018, or $1.7263.
  • [F3]Resigned from the Board of Directors effective December 31, 2017. Fees incurred for 2017 Board and committee services.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION